Photosensitive Epilepsy Completed Phase 2 Trials for JNJ-26489112 (DB15203)

IndicationStatusPhase
DBCOND0039388 (Photosensitive Epilepsy)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00579384A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive EpilepsyTreatment